/Companies

NanoVation Therapeutics

Vancouver, CA · 2 known investors

Find your way into NanoVation Therapeutics

Each arrow is one introduction. Sign up to fill in the first one.

324 people can intro you to Jayesh

Ask Adam Beaudoin to introduce you to Jayesh Kulkarni

You →Adam · together at BC Cancer Agency →Jayesh

228 people can intro you to Dominik

Ask Jamie Chen to introduce you to Dominik Witzigmann

You →Jamie · together at NanoMedicines Innovation Network →Dominik

Sign up to find every way you can get introduced to NanoVation Therapeutics

  • Your email: who you already know at NanoVation Therapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the NanoVation Therapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

NanoVation Therapeutics develops lipid nanoparticle (LNP) and mRNA delivery technologies for gene therapies, supporting drug development partners across mRNA synthesis, LNP formulation, and preclinical delivery optimization. It works with pharmaceutical and biotech partners on end-to-end gene therapy delivery.

Founders & leadership

PCPieter Cullis
Pieter CullisFounder
DWDominik Witzigmann
Dominik WitzigmannCo-founder of NanoVation Therapeutics, Dominik Witzigmann previously led translational nanomedicine projects at international institutions and held leadership positions within the NanoMedicines Innovation Network focused on delivery technology optimization.
JKJayesh Kulkarni
Jayesh KulkarniHe has conducted research on lipid nanoparticle-based gene therapies, with experience in both academic and contract manufacturing organizations spanning early-stage research, scale-up, and manufacturing operations.
ZJZach Jonasson
Zach Jonasson
DMDavid Main
David Main

Investors · 2

In the news

Frequently asked questions

What does NanoVation Therapeutics do?
NanoVation Therapeutics develops lipid nanoparticle (LNP) and mRNA delivery technologies for gene therapies, supporting drug development partners across mRNA synthesis, LNP formulation, and preclinical delivery optimization. It works with pharmaceutical and biotech partners on end-to-end gene therapy delivery.
Who founded NanoVation Therapeutics?
NanoVation Therapeutics was founded by Pieter Cullis, Dominik Witzigmann, Jayesh Kulkarni, Zach Jonasson, David Main.
Who are NanoVation Therapeutics's investors?
NanoVation Therapeutics's investors include Convergent Ventures, Innovation UBC.
Where is NanoVation Therapeutics headquartered?
NanoVation Therapeutics is headquartered in Vancouver, CA.